166 related articles for article (PubMed ID: 4129366)
21. The occurrence of SV40-Neutralizing antibodies in sera of patients with genitourinary carcinoma.
Shah KV; Palma LD; Murphy GP
J Surg Oncol; 1971; 3(4):443-50. PubMed ID: 4329010
[No Abstract] [Full Text] [Related]
22. Alpha-fetoprotein as a marker of embryo-specific differentiations in normal and tumor tissues.
Abelev GI
Transplant Rev; 1974; 20(0):3-37. PubMed ID: 4135841
[No Abstract] [Full Text] [Related]
23. Serum ribonuclease in urologic cancer. Relation to host immunocompetence.
Catalona WJ; Chretien PB; Matthews WJ; Tarpley JL
Urology; 1973 Nov; 2(5):577-81. PubMed ID: 4797457
[No Abstract] [Full Text] [Related]
24. [Value of alpha-globulin as a biological tracer in urogenital cancer].
Gastón de Iriarte E; López-García JA; Hidalgo L; Mendoza M; Martínez-Piñeiro JA
Actas Urol Esp; 1978; 2(3):119-26. PubMed ID: 79304
[No Abstract] [Full Text] [Related]
25. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)].
Hering H; Hering FJ; Weidner W
Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of host immunocompetence in urologic cancer patients.
Catalona WJ; Smolev JK; Harty JI
J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475
[TBL] [Abstract][Full Text] [Related]
27. [6 cases of second primary neoplasms].
Ardiles A; Aldunate C; Lagos M; Larraín P; Martínez C; Olivares R
Rev Med Chil; 1990 Nov; 118(11):1291-3. PubMed ID: 1967110
[No Abstract] [Full Text] [Related]
28. Immunotherapy in genitourinary neoplasia.
Droller MJ
J Urol; 1985 Jan; 133(1):1-5. PubMed ID: 2578065
[No Abstract] [Full Text] [Related]
29. Defective monocyte function in patients with genitourinary carcinoma.
Hausman MS; Brosman S; Snyderman R; Mickey MR; Fahey J
J Natl Cancer Inst; 1975 Nov; 55(5):1047-54. PubMed ID: 1107568
[TBL] [Abstract][Full Text] [Related]
30. [Immunotherapy in uropathology].
Verkarre V; Roussel H; Granier C; Tartour E; Allory Y
Ann Pathol; 2017 Feb; 37(1):90-100. PubMed ID: 28111042
[TBL] [Abstract][Full Text] [Related]
31. [Immunologic aspects in urologic tumors].
Ackermann R
Med Klin; 1980 Jun; 75(12):436-41. PubMed ID: 6156392
[No Abstract] [Full Text] [Related]
32. Skin testing in genitourinary carcinoma: 2-year followup.
Decenzo JM; Allison R; Leadbetter GW
J Urol; 1975 Aug; 114(2):271-3. PubMed ID: 1171996
[TBL] [Abstract][Full Text] [Related]
33. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):343-5. PubMed ID: 748791
[TBL] [Abstract][Full Text] [Related]
34. Further studies on an immunoenzymatic assay for herpes simplex virus tumor-associated antigen.
Tarro G; Flaminio G; Maturo S; Esposito C; Cocchiara R
Clin Immunol Immunopathol; 1982 Oct; 25(1):126-32. PubMed ID: 6295672
[No Abstract] [Full Text] [Related]
35. Novel immunotherapies in GU malignancies.
Drakaki A; McDermott DF
Curr Oncol Rep; 2013 Jun; 15(3):224-31. PubMed ID: 23519772
[TBL] [Abstract][Full Text] [Related]
36. The effects of treatment on delayed cutaneous hypersensitivity responses (DNCB, croton oil, and recall antigen) in patients with genitourinary cancer.
Elhilali MM; Brosman SA; Vescera C; Paul JG; Fahey JL
Cancer; 1978 May; 41(5):1765-70. PubMed ID: 647626
[No Abstract] [Full Text] [Related]
37. Adjuvant therapy for genitourinary cancer.
Messing E; deKernion JB
Surg Clin North Am; 1981 Dec; 61(6):1331-46. PubMed ID: 7198295
[No Abstract] [Full Text] [Related]
38. Cutaneous response to dinitrochlorobenzene in patients with genito-urinary cancers.
Duclos H; Schwarzenberg L; Duclos SH; Hugues H; Kuss R
Biomedicine; 1977 Jan; 27(1):43-7. PubMed ID: 856314
[TBL] [Abstract][Full Text] [Related]
39. A plasma factor inhibiting lymphocyte reactivity in urologic cancer patients.
McLaughlin AP; Brooks JD
J Urol; 1974 Sep; 112(3):366-72. PubMed ID: 4546711
[No Abstract] [Full Text] [Related]
40. [The significance of lymphocytic infiltration in urologic tumors: studies of distributions of B and T-lymphocytes and its subsets, and functional analysis of the infiltrating lymphocytes (author's transl)].
Akaza H
Nihon Hinyokika Gakkai Zasshi; 1981 Jan; 72(1):86-97. PubMed ID: 6974272
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
